In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of SELLAS Life Sciences Group Inc (NASDAQ: SLS) was $1.17 for the day, down -1.68% from the previous closing price of $1.19. In other words, the price has decreased by -$1.68 from its previous closing price. On the day, 1.05 million shares were traded.
Ratios:
Our analysis of SLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.26 and its Current Ratio is at 2.26. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.
On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.
Stock Price History:
Over the past 52 weeks, SLS has reached a high of $1.84, while it has fallen to a 52-week low of $0.77. The 50-Day Moving Average of the stock is -0.35%, while the 200-Day Moving Average is calculated to be -2.96%.
Shares Statistics:
A total of 78.58M shares are outstanding, with a floating share count of 76.95M. Insiders hold about 2.08% of the company’s shares, while institutions hold 7.88% stake in the company.
